Createc’s ground-breaking robot
Interviews are conducted by The Oxford Trust to give insight into the science and tech businesses they support in their innovation centres: the Oxford Centre for Innovation and the Wood Centre for Innovation.
Createc has been developing smart radiation detection and 3D gamma radiation mapping technology over the last few years. Their ‘N-Visage®’ sensor has been deployed worldwide, including at the Fukushima Daichi nuclear power plant in Japan after the devastating earthquake and tsunami in 2011.
The Oxford Robotics Institute (ORI) has developed a state-of-the art, autonomous navigation system called ‘VILENS’ or Visual Inertial Legged Navigation System. The system allows robots to navigate hazardous sites and collate data remotely.
Combined for the first time, the N-Visage®-VILENS system can be installed on all types of robot to solve dangerous work-place challenges and because it processes the data in real time can analyse the situation better than humans.
The advantage of the combined system is that it can be attached to any robot suitable for the particular site under exploration – from a four-wheel drive to a legged robot, like Spot, – and avoids the need for a dedicated robotics development project for each new situation, saving time and cost.
This capability will be invaluable both in decommissioning nuclear sites, where better data leads to cheaper, quicker projects, and in accident response, where rapidly gathering good information is crucial to effective accident management.
Createc is also channel partner for Boston Dynamics enabling distribution of their Spot robot to UK buyers.
The Oxford Robotics Institute (ORI) is an interdisciplinary division within the University of Oxford’s Department of Engineering Science.
For more information about Createc, see here
Five minutes with Rhys Newman, Co-Founder & CSO of Visionary Machines
We spoke to Dr Rhys Newman, Co-Founder and Chief Scientific Officer, about Visionary Machines and the software they are developing to create superhuman vision for machines.
Five minutes with Alex Batchelor, Co-founder & CEO at OxDX
OxDX Ltd has moved into R&D labs at the Trust’s Wood Centre for Innovation to commercialise a novel approach of detecting pathogens by the unique light signature they emit when made fluorescent.
Five minutes with James Peach, Co-founder & CEO at Human Centric Drug Discovery
Starting with migraines, Human Centric Drug Discovery is relying on human data to find a new generation of drugs to treat brain disorders.